Skip to content

Public FDA record

Z-0123-2022: EPIQ CVxi Diagnostic Ultrasound Systems, Product Code: 795232

Recall record Z-0123-2022 for Philips Ultrasound Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0123-2022
Company in FDA record
Philips Ultrasound Inc
FDA record creation date
Oct 16, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ultrasound system software issue can cause an EchoNavigator error notification, leading to an unresponsive system, necessitating system restart, which could lead to therapy/treatment delay and/or unnecessary therapy/treatment. Can occur during ultrasound-guided TEE with EchoNavigator, if secondary screen capture is enabled and user presses other system buttons before secondary capture completed.

Source facts

Action
On 09/21/21, correction notices were sent to customers. Customers were asked to do the following: Identify affected devices by determining the software version using the following steps: Instructions for how to determine the software version of your EPIQ CVxi Ultrasound System: 1. Power up the system and allow it to complete the boot sequence, 2. Press Support on the right side of the control panel, 3. Under System Management, click System Information, 4. The software version is listed in the Software Information Section. The recalling firm recommends that you disable the secondary screen capture feature (i.e., Image Export Capture Setting) in the EchoNavigator system settings to prevent the system from becoming unresponsive due to this issue. The secondary screen recording feature is enabled as a default setting for all EchoNavigator based TEE exams. A recalling firm Field Service Engineer will contact you to schedule a software update to permanently resolve the issue. Please promptly complete and return the attached response form. If there are additional questions, contact your local firm representative: 1-800-722-9377 and reference FCO79500548.
Initiated
2021-09-21
Root cause
Software design
Terminated
2024-04-12
Distribution
US: MI, AZ, IA, TN, OH, CO, WI, NY, NJ, NC, LA, IL, CA, KY, IN, MD, TX, PA. OUS: Denmark, Latvia, Belgium, Hungary, Argentina, Canada, Spain, Germany, Greece, Korea, Republic of Japan, France, Australia, Egypt, Switzerland, Italy, Senegal, Israel, Indonesia, Netherlands, Hong Kong, United Kingdom, Poland, Finland, India, New Zealand
Recall number
Z-0123-2022
Recall status
Terminated
CDRH record ID
189406
FDA record created
2021-10-16
Recall event number
88728

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗